JP2013508279A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508279A5
JP2013508279A5 JP2012534259A JP2012534259A JP2013508279A5 JP 2013508279 A5 JP2013508279 A5 JP 2013508279A5 JP 2012534259 A JP2012534259 A JP 2012534259A JP 2012534259 A JP2012534259 A JP 2012534259A JP 2013508279 A5 JP2013508279 A5 JP 2013508279A5
Authority
JP
Japan
Prior art keywords
compound
group
salt
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012534259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/052126 external-priority patent/WO2011046851A1/en
Publication of JP2013508279A publication Critical patent/JP2013508279A/ja
Publication of JP2013508279A5 publication Critical patent/JP2013508279A5/ja
Withdrawn legal-status Critical Current

Links

JP2012534259A 2009-10-15 2010-10-11 スピロピペリジン化合物および糖尿病治療のためのその医薬用途 Withdrawn JP2013508279A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25183909P 2009-10-15 2009-10-15
US61/251,839 2009-10-15
US30333410P 2010-02-11 2010-02-11
US61/303,334 2010-02-11
PCT/US2010/052126 WO2011046851A1 (en) 2009-10-15 2010-10-11 Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes

Publications (2)

Publication Number Publication Date
JP2013508279A JP2013508279A (ja) 2013-03-07
JP2013508279A5 true JP2013508279A5 (cg-RX-API-DMAC10.html) 2013-11-07

Family

ID=43719548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012534259A Withdrawn JP2013508279A (ja) 2009-10-15 2010-10-11 スピロピペリジン化合物および糖尿病治療のためのその医薬用途

Country Status (25)

Country Link
US (1) US8383642B2 (cg-RX-API-DMAC10.html)
EP (1) EP2488500A1 (cg-RX-API-DMAC10.html)
JP (1) JP2013508279A (cg-RX-API-DMAC10.html)
KR (1) KR20120051777A (cg-RX-API-DMAC10.html)
CN (1) CN102574807A (cg-RX-API-DMAC10.html)
AR (1) AR078522A1 (cg-RX-API-DMAC10.html)
AU (1) AU2010307094A1 (cg-RX-API-DMAC10.html)
BR (1) BR112012008889A2 (cg-RX-API-DMAC10.html)
CA (1) CA2777775A1 (cg-RX-API-DMAC10.html)
CL (1) CL2012000921A1 (cg-RX-API-DMAC10.html)
CO (1) CO6531458A2 (cg-RX-API-DMAC10.html)
CR (1) CR20120177A (cg-RX-API-DMAC10.html)
DO (1) DOP2012000105A (cg-RX-API-DMAC10.html)
EA (1) EA201270560A1 (cg-RX-API-DMAC10.html)
EC (1) ECSP12011799A (cg-RX-API-DMAC10.html)
IL (1) IL218344A0 (cg-RX-API-DMAC10.html)
MA (1) MA33662B1 (cg-RX-API-DMAC10.html)
MX (1) MX2012004420A (cg-RX-API-DMAC10.html)
NZ (1) NZ598972A (cg-RX-API-DMAC10.html)
PE (1) PE20121437A1 (cg-RX-API-DMAC10.html)
PH (1) PH12012500705A1 (cg-RX-API-DMAC10.html)
TN (1) TN2012000152A1 (cg-RX-API-DMAC10.html)
TW (1) TW201124415A (cg-RX-API-DMAC10.html)
WO (1) WO2011046851A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201202560B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2411395T1 (sl) 2009-03-23 2013-07-31 Glenmark Pharmaceuticals S.A. Furopirimidindionski derivati kot TRPA1 modulatorji
EP2411393B1 (en) 2009-03-23 2014-01-22 Glenmark Pharmaceuticals S.A. Fused pyrimidine-dione derivatives as trpa1 modulators
AR078948A1 (es) 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes
CN102712610B (zh) 2009-12-25 2015-03-04 持田制药株式会社 新的3-羟基-5-芳基异噻唑衍生物
WO2012046869A1 (ja) 2010-10-08 2012-04-12 持田製薬株式会社 環状アミド誘導体
CA2829351A1 (en) 2011-03-11 2012-09-20 Intercontinental Great Brands Llc System and method of forming multilayer confectionery
CN105153146A (zh) 2011-04-27 2015-12-16 持田制药株式会社 新的3-羟基异噻唑1-氧化物衍生物
WO2012147516A1 (ja) 2011-04-28 2012-11-01 持田製薬株式会社 環状アミド誘導体
AR087451A1 (es) * 2011-08-17 2014-03-26 Lilly Co Eli Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes
WO2013139341A1 (en) * 2012-03-20 2013-09-26 Syddansk Universitet Gpr120 receptor modulators
WO2013185766A1 (en) * 2012-06-15 2013-12-19 Syddansk Universitet Gpr120 receptor modulators
US9133163B2 (en) 2012-11-16 2015-09-15 Bristol-Myers Squibb Company Dihydropyrazole GPR40 modulators
KR101569522B1 (ko) * 2013-04-18 2015-11-17 현대약품 주식회사 신규한 3-(4-(벤질옥시)페닐)헥스-4-이노익 산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물
EP3068788A1 (en) 2013-11-14 2016-09-21 Cadila Healthcare Limited Novel heterocyclic compounds
US20150351889A1 (en) 2014-06-05 2015-12-10 Vivex Biomedical Inc. Dynamic Biometric Mesh
MX387086B (es) * 2014-10-17 2025-03-19 Hyundai Pharm Co Ltd Preparacion compuesta, que contiene derivado novedoso de acido 3-(4-(benciloxi)fenil)hex-4-inoico y otro ingrediente activo, para prevenir o tratar enfermedades metabolicas
CN109666027A (zh) * 2017-10-17 2019-04-23 中国科学院上海药物研究所 一类酰胺结构的gpr40激动剂化合物及其用途
DK3737470T5 (da) 2018-01-08 2024-05-27 Celon Pharma Sa 3-phenyl-4-hexynsyrederivater som gpr40-agonister
KR102708681B1 (ko) 2018-02-13 2024-09-26 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
EP3781556B1 (en) 2018-04-19 2025-06-18 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
PL3820572T3 (pl) 2018-07-13 2024-02-26 Gilead Sciences, Inc. Inhibitory pd-1/pd-l1
CA3117199C (en) 2018-10-24 2024-03-19 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
CN114945560B (zh) 2019-10-07 2024-08-13 卡尔优普公司 Gpr119激动剂
CN115667277A (zh) 2020-02-28 2023-01-31 卡尔优普公司 Gpr40激动剂
UY39222A (es) 2020-05-19 2021-11-30 Kallyope Inc Activadores de la ampk
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1385514T1 (sl) * 2001-04-18 2009-04-30 Euro Celtique Sa Spiroindenske in spiroindanske spojine
EP1613601A4 (en) * 2003-04-04 2007-05-02 Merck & Co Inc ACYLATED SPIROPIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS
US7504506B2 (en) * 2003-11-04 2009-03-17 Elixir Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
WO2005051890A1 (en) 2003-11-19 2005-06-09 Smithkline Beecham Corporation Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40
BRPI0508098A (pt) 2004-02-27 2007-07-17 Amgen Inc compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
EP1731505B1 (en) * 2004-03-30 2015-01-14 Takeda Pharmaceutical Company Limited Alkoxyphenylpropanoic acid derivatives
EP1924546A1 (en) * 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
EP2061760A1 (en) 2006-09-07 2009-05-27 Amgen, Inc Benzo-fused compounds for use in treating metabolic disorders
SI2202216T1 (sl) * 2007-10-26 2012-10-30 Japan Tobacco Inc Spiro obročna spojina in njena uporaba za medicinske namene
JP2011504499A (ja) * 2007-11-21 2011-02-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ トリプターゼ阻害剤として使用するためのスピロピペリジン
AR078948A1 (es) 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes

Similar Documents

Publication Publication Date Title
JP2013508279A5 (cg-RX-API-DMAC10.html)
JP2013512277A5 (cg-RX-API-DMAC10.html)
JP2013518107A5 (cg-RX-API-DMAC10.html)
JP2012525393A5 (cg-RX-API-DMAC10.html)
JP2013542247A5 (cg-RX-API-DMAC10.html)
JP2009535307A5 (cg-RX-API-DMAC10.html)
JP2010077141A5 (cg-RX-API-DMAC10.html)
JP2014511891A5 (cg-RX-API-DMAC10.html)
JP2010501584A5 (cg-RX-API-DMAC10.html)
JP2013537203A5 (cg-RX-API-DMAC10.html)
JP2012505836A5 (cg-RX-API-DMAC10.html)
JP2013510120A5 (cg-RX-API-DMAC10.html)
JP2009535352A5 (cg-RX-API-DMAC10.html)
JP2013509429A5 (cg-RX-API-DMAC10.html)
JP2011504903A5 (cg-RX-API-DMAC10.html)
JP2009523760A5 (cg-RX-API-DMAC10.html)
JP2013507439A5 (cg-RX-API-DMAC10.html)
JP2009504763A5 (cg-RX-API-DMAC10.html)
JP2014505107A5 (cg-RX-API-DMAC10.html)
JP2014518266A5 (cg-RX-API-DMAC10.html)
JP2013500986A5 (cg-RX-API-DMAC10.html)
JP2013534248A5 (cg-RX-API-DMAC10.html)
JP2014508804A5 (cg-RX-API-DMAC10.html)
JP2019526596A5 (cg-RX-API-DMAC10.html)
JP2020507589A5 (cg-RX-API-DMAC10.html)